Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Monday.com Reports Q4 Results, Joins AN2 TherapeuticsAnd Other Big Stocks Moving Lower In Monday's Pre-Market Session

Published 12/02/2024, 13:16
Updated 12/02/2024, 14:40
© Reuters.  Monday.com Reports Q4 Results, Joins AN2 TherapeuticsAnd Other Big Stocks Moving Lower In Monday's Pre-Market Session
WYNN
-
MANU
-
PGEN
-
LRMR
-
TIXT
-
MNDY
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stock futures were mixed this morning, with the Dow futures trading lower by around 45 points on Monday.

Shares of monday.com Ltd. (NASDAQ: MNDY) fell sharply in today’s pre-market trading after the company reported fourth-quarter financial results.

Monday.com posted adjusted earnings of 65 cents per share on sales of $202.57 million.

monday.com shares dipped 9% to $214.69 in pre-market trading.

Here are some big stocks recording losses in today’s pre-market trading session.

  • AN2 Therapeutics, Inc. (NASDAQ: ANTX) shares dipped 72% to $5.59 in pre-market trading as the company said it will voluntarily pause enrollment in Phase 3 part of Phase 2/3 pivotal clinical trial evaluating epetraborole for the treatment-refractory Mycobacterium Avium Complex (MAC) lung disease.
  • TELUS International (Cda) Inc. (NYSE: TIXT) shares fell 11% to $8.37 in pre-market trading. On Friday, TELUS International posted downbeat fourth-quarter results.
  • Applied Digital Corporation (NASDAQ: APLD) shares dipped 7.5% to $4.88 in pre-market trading after gaining 5% on Friday. Applied Digital, last month, reported worse-than-expected second-quarter financial results.
  • Precigen, Inc. (NASDAQ: PGEN) shares declined 6.4% to $1.31 in pre-market trading. Precigen, last month, received Orphan Drug designation for PRGN-2012 for the treatment of recurrent respiratory papillomatosis from the European Commission.
  • Microvast Holdings, Inc. (NASDAQ: MVST) shares slipped 5% to $0.96 in pre-market trading after gaining 9% on Friday.
  • Wynn Resorts, Limited (NASDAQ: WYNN) shares fell 4.4% to $101.00 in pre-market trading. Wynn Resorts, last week, reported better-than-expected fourth-quarter financial results.
  • Larimar Therapeutics, Inc. (NASDAQ: LRMR) shares fell 3.9% to $7.46 in pre-market trading after surging around 24% on Friday.
  • Manchester United plc (NYSE: MANU) shares fell 3% to $20.50 in pre-market trading.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Now Read This: Waste Management, Goodyear Tire And 3 Stocks To Watch Heading Into Monday

Don’t forget to check out our premarket coverage here

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.